Herpes simplex virus (HSV) infections are efficiently treated with antiviral drugs such as
acyclovir (ACV). However, resistance has been reported, mainly among immunocompromised …

Funding-Quanterix provided the kits for this study free of charge. 37 Conflict of interest–Pons
S, Oriol G, Brengel-Pesce K, Mouton W, Compagnon C are Biomérieux® 38 employeers. …

We report the strategy leading to the first detection of variant of concern 202012/01 (VOC) in
France (21 December 2020). First, the spike (S) deletion H69–V70 (ΔH69/ΔV70), identified …

IFN-I and IFN-III immunity in the nasal mucosa is poorly characterized during SARS-CoV-2
infection. We analyze the nasal IFN-I/III signature, namely the expression of ISGF-3–…

Since the beginning of the COVID-19 outbreak, SARS-CoV-2 whole-genome sequencing (WGS)
has been performed at unprecedented rate worldwide with the use of very diverse Next-…

The widespread use of acyclovir (ACV) and the increasing number of immunocompromised
patients have raised concern about an increase in ACV-resistant herpes simplex virus (HSV)…

Fourteen cases of severe acyclovir-resistant herpes simplex virus type 1 (HSV-1) infection,
7 of which showed resistance to foscarnet, were diagnosed among 196 allogeneic stem cell …

Adenovirus infections are a frequent and serious complication following allogeneic
haematopoietic stem cell transplantation (HSCT). The antiviral drugs cidofovir and ribavirin have …

From December 2021-February 2022, an intense and unprecedented co-circulation of
SARS-CoV-2 variants with high genetic diversity raised the question of possible co-infections …

The emergence of SARS-CoV-2 variant 20I/501Y.V1 (VOC-202012/1 or GR/501Y.V1) is
concerning given its increased transmissibility. We reanalysed 11,916 PCR-positive tests (41% …